Marjan Ghaemi | Medicine and Dentistry | Women Researcher Award

Prof. Marjan Ghaemi | Medicine and Dentistry | Women Researcher Award

Prof Tehran university of medical sciences at Iran

Dr. Marjan Ghaemi is an accomplished gynecologist, obstetrician, and infertility specialist with a fellowship in endocrinology. She serves as an Assistant Professor at Vali-E-Asr Reproductive Health Research Center, Tehran University of Medical Sciences. With a strong background in both clinical and research fields, she has dedicated her career to advancing reproductive health. Her expertise spans infertility treatments, reproductive endocrinology, gynecological oncology, and minimally invasive surgery. Additionally, she has played a significant role in medical research and education, holding editorial positions in esteemed journals. Dr. Ghaemi has also contributed to digital health innovations, developing medical IT solutions and e-learning programs. With extensive experience in clinical research, trial management, and evidence-based medicine, she has been instrumental in improving reproductive healthcare. Her leadership in both academia and clinical practice has positioned her as a key figure in the field. Passionate about bridging the gap between research and patient care, she continues to explore new frontiers in reproductive medicine. Her contributions to gynecology and infertility research make her a strong contender for prestigious awards. She strives to integrate cutting-edge technology and medical advancements to enhance women’s healthcare, both nationally and internationally.

Professional Profile

Education

Dr. Marjan Ghaemi has an extensive educational background in medicine, gynecology, and reproductive endocrinology. She obtained her Doctorate in Medicine (MD) from Tehran University of Medical Sciences (TUMS), where she conducted research on the prevalence of polycystic ovary syndrome (PCOS) in adolescents. She further pursued specialization in obstetrics and gynecology at TUMS, achieving the highest national board exam score in OB/GYN in 2019. Her residency research focused on evaluating the quality of life in gynecological cancer patients using a web-based study. Dr. Ghaemi then completed a fellowship in infertility and endocrinology at TUMS, where she conducted a randomized controlled trial comparing different ovarian stimulation protocols in IVF patients with PCOS. Her educational achievements reflect her strong academic foundation and commitment to evidence-based medicine. With a focus on reproductive endocrinology, infertility treatments, and gynecological oncology, her research and clinical training have positioned her as a leader in her field. Her education not only provided her with deep clinical expertise but also honed her research skills, allowing her to contribute significantly to scientific advancements. Through her academic journey, she has consistently demonstrated excellence in both research and patient care, making significant contributions to reproductive medicine.

Professional Experience

Dr. Marjan Ghaemi has a distinguished professional career in clinical practice, academia, and research. She currently serves as an Assistant Professor at Vali-E-Asr Reproductive Health Research Center, TUMS, where she focuses on infertility treatments and reproductive endocrinology. She previously worked as an Assistant Professor at Kamali Hospital, Alborz University of Medical Sciences. Her expertise includes advanced infertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and minimally invasive gynecological surgeries. Dr. Ghaemi has also played a significant role in scientific publishing, serving as the Chief Editor of Fertility, Gynecology and Andrology and as an Associate Editor for the Journal of Family and Reproductive Health. Her research leadership extends to clinical trials and medical IT innovations. As a Clinical Research Manager at Farzan Clinical Research, she supervised multiple Phase II-IV studies and contributed to the development of digital health solutions, including e-learning platforms and medical applications. She has also worked extensively in hospital settings, managing complex cases in gynecology, obstetrics, and infertility. Her vast experience in research, patient care, and medical education makes her a well-rounded professional dedicated to advancing women’s health and reproductive medicine.

Research Interests

Dr. Marjan Ghaemi’s research focuses on reproductive endocrinology, infertility, and gynecological health. She has a particular interest in polycystic ovary syndrome (PCOS), exploring its prevalence, impact on fertility, and treatment options. Her work in in-vitro fertilization (IVF) has contributed to optimizing ovarian stimulation protocols, improving success rates for women with infertility. She is also interested in recurrent pregnancy loss and male infertility, expanding her research to encompass both partners in reproductive challenges. Additionally, Dr. Ghaemi has investigated the quality of life in gynecological cancer patients, seeking ways to enhance supportive care. Her research extends to hormonal therapies, reproductive surgeries, and minimally invasive techniques, contributing to advancements in assisted reproductive technology (ART). Another key area of her work involves the integration of digital health in reproductive medicine, including e-learning platforms and telemedicine for patient education. She is passionate about bridging the gap between clinical practice and research, ensuring that scientific advancements translate into better patient outcomes. Her multidisciplinary approach combines clinical expertise with innovative research methodologies, making her a leader in reproductive medicine. Through her studies, she aims to improve fertility treatments and reproductive health care, benefiting both patients and the scientific community.

Research Skills

Dr. Marjan Ghaemi possesses advanced research skills in clinical trials, reproductive endocrinology, and gynecological health. She is proficient in designing and conducting randomized controlled trials (RCTs), as demonstrated in her research on ovarian stimulation protocols in IVF. She has extensive experience in medical research methodologies, data analysis, and evidence-based practice. Her expertise in site monitoring, project management, and medical reporting has made her a key contributor to clinical research studies. Additionally, she has strong skills in digital health and medical IT, having developed e-learning platforms, mobile health applications, and smart e-health projects. Dr. Ghaemi’s editorial roles in leading medical journals have enhanced her abilities in scientific publishing, peer review, and manuscript editing. She is also skilled in medical writing and literature reviews, ensuring high-quality contributions to academic publications. Her experience in biostatistics and research ethics allows her to conduct rigorous and ethically sound studies. Furthermore, she has expertise in advanced imaging techniques such as gynecological and infertility ultrasound, enhancing her research capabilities in diagnostic medicine. Her diverse skill set in clinical and digital research makes her a valuable figure in reproductive medicine, contributing to scientific advancements and improved patient care.

Awards and Honors

Dr. Marjan Ghaemi has received several awards and honors in recognition of her academic excellence and contributions to reproductive medicine. She achieved the highest national board exam score in OB/GYN in 2019, demonstrating her outstanding medical knowledge and expertise. Her research on polycystic ovary syndrome (PCOS) and infertility treatments has been acknowledged in various academic and clinical circles. She has also played a pivotal role in medical research and journal editing, earning recognition for her editorial leadership in Fertility, Gynecology and Andrology and Journal of Family and Reproductive Health. As a Clinical Research Manager at Farzan Clinical Research, she was part of a team that earned national recognition as a top knowledge-based institute. Additionally, her contributions to medical IT and e-learning have been praised, as she has led projects in digital health solutions for reproductive medicine. Her work in gynecological cancer quality-of-life studies has also been highlighted in medical research communities. With her achievements in academia, research, and digital innovation, Dr. Ghaemi continues to be recognized as a leading figure in reproductive health and infertility research, making significant contributions to the field.

Conclusion

Dr. Marjan Ghaemi is an exceptional researcher and clinician in reproductive medicine, with expertise spanning gynecology, infertility, and endocrinology. Her contributions to clinical research, medical education, and digital health innovation have positioned her as a leader in the field. With a strong academic background, she has conducted impactful research on PCOS, IVF, and gynecological health, improving fertility treatment outcomes. Her editorial roles in leading journals further emphasize her dedication to advancing scientific knowledge. She has also played a key role in integrating digital health solutions into reproductive medicine, enhancing patient education and research methodologies. While she has achieved significant milestones, expanding her international collaborations and high-impact publications could further elevate her global presence. Overall, her dedication to evidence-based medicine and patient-centered care makes her a strong candidate for prestigious research awards. Dr. Ghaemi’s work is instrumental in shaping the future of reproductive health, and she remains committed to pioneering advancements in infertility treatments and women’s healthcare. With her expertise, leadership, and passion for research, she continues to make remarkable contributions to medical science and patient well-being.

Publications Top Notes

  1. Title: Uterus transplantation: A bibliometric review of six-decade study from 1960 to 2024
    Authors: R. Akbari, M. Ghaemi, Z.Y. Panahi
    Year: 2025
    Citations: 1

  2. Title: The Effectiveness of Letrozole Alone or in Combination with Methotrexate in the Management of Ectopic Pregnancy, A Systematic Review and Meta-Analysis
    Authors: A.M. Tarafdari, F. Keikha, F. Asadi, M. Forouzin, M. Ghaemi
    Year: 2024

  3. Title: Knowledge, attitudes, and practices of healthcare providers among women oncofertility in Iran: a cross-sectional study
    Authors: M. Ghaemi, I. Rokhzadi, M. Dashtkoohi, N. Eshraghi, M. Fakehi
    Year: 2024

  4. Title: Potential efficacy of digital polymerase chain reaction for non-invasive prenatal screening of autosomal aneuploidies: a systematic review and meta-analysis
    Authors: M. Parsaei, M. Dashtkoohi, T. Salmani, M. Ghaemi, S. Hantoushzadeh
    Year: 2024

  5. Title: The association between increased fetal movements in the third trimester and perinatal outcomes; a systematic review and meta-analysis
    Authors: S. Hantoushzadeh, O. Kohandel Gargari, M. Jamali, Z. Panahi, G.R. Habibi
    Year: 2024

  6. Title: Breast Implant Illness as a Challenging Disorder in Clinics
    Authors: F.G. Vahdani, M. Ghaemi, M. Haddadi
    Year: 2024

  7. Title: The association between the amount of fetal fraction in cell-free DNA testing and adverse pregnancy outcomes: A cohort study
    Authors: M. Aryavand, M. Noorzadeh, M. Ghaemi, S.E. Delfan, V. Marsoosi
    Year: 2024

  8. Title: Analysis of medico-legal claims related to deliveries: Caesarean section vs. vaginal delivery
    Authors: N. Eshraghi, M. Ghaemi, Z. Shabannejad, Z. Mansouri, S. Hantoushzadeh
    Year: 2024
    Citations: 1

  9. Title: The effect of Myo-inositol on improving sperm quality and IVF outcomes: A systematic review and meta-analysis
    Authors: M. Ghaemi, N. Seighali, A. Shafiee, Z.Y. Panahi, S. Hantoushzadeh
    Year: 2024
    Citations: 1

 

 

Berta Mosleh | Thoracic Surgery | Best Researcher Award

Dr. Berta Mosleh | Thoracic Surgery | Best Researcher Award

Department of Thoracic Surgery from Medical University of Vienna, Austria.

Berta Mosleh, MD, MSc, is a dedicated medical professional with a strong background in thoracic surgery and oncological research. She is currently pursuing a Doctoral Programme in Applied Medical Science at the Medical University of Vienna, focusing on inflammatory proteins and growth factors as biomarkers in malignant pleural mesothelioma. With a medical degree from the Medical University of Vienna and a master’s in economics from Corvinus University of Budapest, she combines clinical expertise with analytical skills. Dr. Mosleh has extensive experience in thoracic surgery, lung cancer research, and minimally invasive surgical procedures. She has contributed significantly to medical literature, with multiple peer-reviewed publications exploring the molecular and clinical aspects of thoracic malignancies. Through her work at Vienna General Hospital and involvement in various research programs, she has gained expertise in interventional bronchoscopy, cytoreductive surgery, and hyperthermic intrathoracic chemotherapy. Her research interests include oncological biomarkers, immunotherapy, and sex-based differences in lung cancer susceptibility. Dr. Mosleh’s commitment to advancing thoracic oncology has earned her recognition in the medical community. With a passion for research and innovation, she strives to enhance treatment strategies and patient outcomes in thoracic malignancies.

Professional Profile

Education

Dr. Berta Mosleh has a multidisciplinary academic background spanning medicine and economics. She is currently enrolled in the Doctoral Programme of Applied Medical Science at the Medical University of Vienna, where she is researching biomarkers for malignant pleural mesothelioma. She obtained her Doctor of Medicine (MD) degree from the Medical University of Vienna in 2019, equipping her with extensive clinical knowledge and surgical expertise. Before transitioning into medicine, Dr. Mosleh earned a Master’s degree in Economics from Corvinus University of Budapest, specializing in Business Administration and Financial Accounting. This diverse academic foundation provides her with a unique perspective on healthcare management and medical research. Throughout her education, she has engaged in numerous internships and research projects, solidifying her expertise in thoracic oncology, minimally invasive surgery, and pulmonary disease management. Her dedication to academic excellence is evident in her ongoing pursuit of medical advancements through research and clinical practice.

Professional Experience

Dr. Berta Mosleh has accumulated a wealth of experience in thoracic surgery and research. Since October 2019, she has been a surgical resident at Vienna General Hospital’s Department of Thoracic Surgery, where she actively participates in the “Thoracic Malignancies Research Program” and the “Malignant Pleural Mesothelioma Treatment and Research Program.” She previously served as a surgical and research intern at the same institution, gaining hands-on experience in minimally invasive procedures and oncological treatments. Dr. Mosleh has also contributed to research in general surgery and pulmonology, undertaking internships in internal medicine, orthopedic surgery, and reconstructive surgery. Her early career included positions in business consulting as a risk advisor at Ernst & Young and a financial auditor at Deloitte. This diverse professional background complements her medical expertise, enhancing her ability to analyze complex healthcare data and optimize clinical decision-making. Her commitment to thoracic oncology and continuous learning makes her an asset in both clinical and research settings.

Research Interests

Dr. Berta Mosleh’s research interests center on thoracic oncology, with a focus on malignant pleural mesothelioma, lung cancer, and pleural disease. She is particularly interested in identifying biomarkers for early diagnosis and treatment response in thoracic malignancies. Her research explores inflammatory proteins, growth factors, and immune checkpoint inhibitors to improve therapeutic strategies. Dr. Mosleh also investigates sex-based differences in lung cancer susceptibility and genetic alterations, aiming to refine personalized treatment approaches. Another key area of her research is the role of immunotherapy and targeted treatments in lung cancer and mesothelioma. Her work extends to the assessment of PD-1 and PD-L1 expression in lung cancer, evaluating their impact on disease progression and patient survival. Through her involvement in multiple studies, she aims to bridge the gap between experimental findings and clinical applications, ultimately improving patient care in thoracic oncology.

Research Skills

Dr. Berta Mosleh possesses a strong skill set in both clinical and laboratory research. She has expertise in biomarker analysis, molecular diagnostics, and immunohistochemistry, allowing her to study disease mechanisms at a cellular level. Her proficiency in clinical trial design and statistical analysis enables her to conduct high-quality medical research. She is skilled in various thoracic surgery techniques, including minimally invasive procedures, interventional bronchoscopy, and cytoreductive surgery. Dr. Mosleh is also adept at medical writing and has authored several peer-reviewed publications. Her ability to collaborate with interdisciplinary teams has been instrumental in advancing research projects. Additionally, her background in economics and data analysis enhances her capacity to assess healthcare trends and optimize treatment strategies. With a strong foundation in both clinical and translational research, she continues to contribute to advancements in thoracic oncology and surgical innovation.

Awards and Honors

Dr. Berta Mosleh has received recognition for her contributions to thoracic surgery and cancer research. Her work in identifying biomarkers for malignant pleural mesothelioma has been acknowledged in academic conferences and peer-reviewed journals. She has been invited to present her findings at prestigious medical symposiums, such as the ÖGP | OGTC Jahrestagung and Cancer Update CCC Vienna. Her research on sex-based differences in lung cancer susceptibility has gained attention within the scientific community. Additionally, her role in evaluating PD-1 and PD-L1 expression in lung cancer has contributed to understanding tumor immunology. Dr. Mosleh’s dedication to medical innovation and patient-centered research has earned her respect among colleagues and mentors. As she continues her research in thoracic oncology, she remains committed to furthering advancements in cancer diagnosis and treatment.

Conclusion

Dr. Berta Mosleh is a highly accomplished thoracic surgeon and researcher, dedicated to advancing the understanding and treatment of lung cancer and malignant pleural mesothelioma. With a solid academic foundation, extensive surgical experience, and a passion for oncological research, she has made significant contributions to the medical field. Her expertise in biomarker discovery, immunotherapy, and minimally invasive procedures positions her at the forefront of thoracic oncology. Through her commitment to scientific research and patient care, Dr. Mosleh continues to drive innovation in cancer treatment. Her ability to integrate clinical practice with research findings ensures that her work has a tangible impact on improving patient outcomes. As she progresses in her career, she remains dedicated to enhancing diagnostic tools, refining therapeutic strategies, and mentoring future medical professionals.

Publications Top Notes

  1. Title: Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020s

    • Authors: B.O. Mosleh, Berta O.; P. Sarova, Pavla; S. Zehetmayer, Sonja; M.A. Hoda, Mir Alireza; D.R. Gompelmann, Daniela Rosa
    • Year: 2025
  2. Title: The impact of restricted chests on long-term lung function parameters following lung transplantation in patients with interstitial lung disease

    • Authors: K. Nakanishi, Keita; T. Schweiger, Thomas; S. Schwarz, Stefan; T.F. Chen-Yoshikawa, Toyofumi Fengshi; K. Hoetzenecker, Konrad
    • Year: 2025
    • Citations: 1

 

Antonio Calvo | Surgery | Best Paper Award

Dr. Antonio Calvo | Surgery | Best Paper Award 

Surgeon, at Andalusian Health Service, Spain.

Dr. Antonio Enrique Calvo Durán is a distinguished clinical surgeon specializing in abdominal surgery. Currently, he serves as the Chief Clinical Officer at Servicio Andaluz de Salud, a position he has held since 2009. Dr. Calvo has made significant contributions to hepatobiliary and pancreatic surgery, as well as oncology, particularly in the fields of cancer research and surgical treatments. His extensive clinical and research expertise has earned him recognition in Spain and beyond, making him a key figure in his field.

Profile

ORCID

Education

Dr. Calvo has an impressive academic background, with multiple advanced qualifications in the medical field. He holds a Master’s degree in Hepatobiliary and Pancreatic Surgery from the University of Barcelona (2022) and a series of other specialized diplomas and certifications, including in Oncological Digestive Surgery and Liver Transplantation. He also completed his Medical Degree at the Complutense University of Madrid in 1989.

Experience

With over three decades of experience, Dr. Calvo has contributed to numerous surgical projects and clinical trials. He has been an investigator in the European LiverMetSurvey for colorectal liver metastasis since 2009 and has also served as an evaluator and reviewer for several national and international surgical congresses and journals. His leadership extends to the management of complex surgical cases and clinical protocols in his current role.

Research Interests

Dr. Calvo’s research focuses on hepatobiliary pancreatic surgery, cancer treatment, and liver transplantation. He leads clinical trials on pancreatic cancer and liver metastasis, with particular interest in neoadjuvant therapies and the development of biomarkers for early detection of surgical complications. He is also involved in research projects analyzing the functionality of hepatocytes and the impact of tyrosine kinase inhibitors on cellular metabolism.

Awards

Dr. Calvo has received several prestigious awards, including the Dr. Luis Sagaz Zubelu Award in 2000 for his groundbreaking research on hereditary colon cancer. He has also been recognized for his continuous contributions to medical education and clinical innovation in abdominal surgery.

Publications

Dr. Calvo has authored numerous scientific publications, contributing to journals such as BMC Surgery and PLOS One. His research on the value of vein resection in pancreaticoduodenectomy and the comparison of laparoscopic and open right hemicolectomy techniques has been widely cited. Below are links to some of his key works:

  • BMC Surgery (2019)
    Title: The value of combined vein resection in pancreaticoduodenectomy for pancreatic head carcinoma: A meta-analysis
    Authors: Antonio Enrique Calvo Durán, et al.
    Received: April 1, 2019 | Accepted: June 24, 2019 | Published online: July 8, 2019
    Link to the article
  • PLOS ONE (2019)
    Title: Laparoscopic versus open right hemicolectomy in colon carcinoma: A propensity score analysis of the DGAV StuDoQ|ColonCancer registry
    Authors: Antonio Enrique Calvo Durán, et al.
    Received: May 1, 2019 | Accepted: June 11, 2019 | Published: June 27, 2019
    Link to the article
  • BMC Gastroenterology (2020)
    Title: Retroperitoneal laparoscopic hepatectomy of recurrent hepatocellular carcinoma: Case report and literature review
    Authors: Antonio Enrique Calvo Durán, et al.
    In Press.
    Link to the article

Conclusion

Dr. Antonio Enrique Calvo Durán is undoubtedly a highly qualified candidate for the Best Researcher Award. His clinical expertise, groundbreaking research contributions, leadership in major funded projects, and active role in scientific societies highlight his exemplary commitment to advancing the medical field, particularly in surgical oncology. With continued focus on interdisciplinary research and global collaborations, his potential for further impact is vast. His already significant contributions make him an outstanding candidate for this prestigious award.